US4156718A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Control and reversal of the immunological senescence
Assignee: HELLER JOHN H
•
Filing: 1977-12-12
•
Granted: 1979-05-29
•
Expires: 1997-12-12
Abstract
Abstract The invention relates to a method of controlling and/or reversing the immunological senescence in animals and humans by administering thereto coenzymes Q 4 to at least Q 13 and particularly coenzyme Q 10 .
Inventors
- 👤 Emile G. Bliznakov
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 08:14
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/12; A61P; A61P37/00
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
49 words
The method of reversing the immunological senescence in aged humans and lower animals which comprises internally administering thereto a sufficient amount of a coenzyme Q 4 to at least Q 13 to reverse the depression of the host defense resistance which has been depressed or weakened due to aging.
Claim 2
Independent Claim
49 words
The method of reversing the immunological senescence in aged humans and lower animals which comprises internally administering thereto a sufficient amount of a coenzyme Q 4 to at least Q 13 to reverse the depression of the host defense resistance which has been depressed or weakened due to aging.
Claim 3
Dependent Claim
14 words
The method of claim 1 in which the coenzyme is coenzyme Q 10 .
Claim 4
Independent Claim
50 words
The method of retarding or reversing the immunological senescence in aged humans or lower animals which comprises internally administering thereto a sufficient amount of a coenzyme Q 4 to at least Q 13 to suppress the humoral hemolytic immune response of the host which has been depressed due to aging.
Claim 5
Independent Claim
50 words
The method of retarding or reversing the immunological senescence in aged humans or lower animals which comprises internally administering thereto a sufficient amount of a coenzyme Q 4 to at least Q 13 to suppress the humoral hemolytic immune response of the host which has been depressed due to aging.
Claim 6
Dependent Claim
14 words
The method of claim 3 in which the coenzyme is coenzyme Q 10 .
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1982-05-28 | 1982-11-27 | 1983-05-29 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1986-05-28 | 1986-11-27 | 1987-05-29 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1990-05-28 | 1990-11-27 | 1991-05-29 | $7700.00 | Window Closed / Lapsed |